JOHN R MOORE, the General Counsel of $EWTX, sold 2,098 shares of the company on 08-12-2025 for an estimated $28,097. We received data on the trade from a recent SEC filing. This was a sale of approximately 17.0% of their shares of this class of stock. Following this trade, they now own 10,214 shares of this class of $EWTX stock.
$EWTX Insider Trading Activity
$EWTX insiders have traded $EWTX stock on the open market 18 times in the past 6 months. Of those trades, 4 have been purchases and 14 have been sales.
Here’s a breakdown of recent trading of $EWTX stock by insiders over the last 6 months:
- ADVISORS LLC ORBIMED has made 2 purchases buying 496,771 shares for an estimated $10,000,000 and 0 sales.
- PETER A. THOMPSON has made 2 purchases buying 496,771 shares for an estimated $10,000,000 and 0 sales.
- KEVIN KOCH (President and CEO) has made 0 purchases and 3 sales selling 12,348 shares for an estimated $180,122.
- JOANNE M. DONOVAN (CMO) has made 0 purchases and 2 sales selling 8,049 shares for an estimated $123,676.
- BEHRAD DERAKHSHAN (Chief Business Officer) has made 0 purchases and 2 sales selling 4,182 shares for an estimated $61,184.
- JOHN R MOORE (General Counsel) has made 0 purchases and 2 sales selling 4,028 shares for an estimated $59,853.
- ALAN J RUSSELL (Chief Scientific Officer) has made 0 purchases and 3 sales selling 3,658 shares for an estimated $57,063.
- R MICHAEL CARRUTHERS (Chief Financial Officer) has made 0 purchases and 2 sales selling 2,742 shares for an estimated $40,745.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$EWTX Hedge Fund Activity
We have seen 116 institutional investors add shares of $EWTX stock to their portfolio, and 98 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- PERCEPTIVE ADVISORS LLC added 3,861,791 shares (+143.8%) to their portfolio in Q1 2025, for an estimated $84,959,402
- BRAIDWELL LP added 2,752,023 shares (+111.9%) to their portfolio in Q2 2025, for an estimated $36,079,021
- PARADIGM BIOCAPITAL ADVISORS LP added 1,747,788 shares (+39.8%) to their portfolio in Q2 2025, for an estimated $22,913,500
- SIREN, L.L.C. added 1,463,854 shares (+86.3%) to their portfolio in Q2 2025, for an estimated $19,191,125
- DEEP TRACK CAPITAL, LP removed 1,400,000 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $18,354,000
- BELLEVUE GROUP AG added 1,347,068 shares (+94.3%) to their portfolio in Q2 2025, for an estimated $17,660,061
- FRAZIER LIFE SCIENCES MANAGEMENT, L.P. removed 1,271,245 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $27,967,390
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$EWTX Analyst Ratings
Wall Street analysts have issued reports on $EWTX in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- RBC Capital issued a "Outperform" rating on 08/08/2025
- HC Wainwright & Co. issued a "Buy" rating on 06/30/2025
- Wedbush issued a "Outperform" rating on 04/21/2025
- Piper Sandler issued a "Overweight" rating on 04/02/2025
To track analyst ratings and price targets for $EWTX, check out Quiver Quantitative's $EWTX forecast page.
$EWTX Price Targets
Multiple analysts have issued price targets for $EWTX recently. We have seen 5 analysts offer price targets for $EWTX in the last 6 months, with a median target of $43.0.
Here are some recent targets:
- Leonid Timashev from RBC Capital set a target price of $49.0 on 08/08/2025
- Joseph Pantginis from HC Wainwright & Co. set a target price of $42.0 on 06/30/2025
- Laura Chico from Wedbush set a target price of $43.0 on 04/21/2025
- Louise Chen from Scotiabank set a target price of $14.0 on 04/03/2025
- Yasmeen Rahimi from Piper Sandler set a target price of $51.0 on 04/02/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
